Alembic Pharmaceuticals Gets Final Nod from US FDA for Lamotrigine Orally Disintegrating Tablets
Alembic Pharmaceuticals Gets Final Nod from US FDA for Lamotrigine Orally Disintegrating Tablets is drawing significant interest across the industry.
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for Lamotrigine orally disintegrating tablets in the strengths of 25 mg, 50 mg, 100 mg, and 200 mg,...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Japan's Nikkei falls to one-month low as Middle East conflict intensifies
- Australia Weighs Housing Tax Reform in May Budget, Media Say
- Abxylute’s new Switch 2 controller prototype has one big problem
- Justin Baldoni, Blake Lively Meet in Court Amid Legal Battle
Source: Original →